共 3 条
- [2] MEASURE: a multi-centre, single-arm, observational, 96 week, phase IV study to evaluate treatment adherence when using RebiSmartTM for self-injection of subcutaneous interferon-β 1a in multi-dose cartridges in subjects with relapsing multiple sclerosis JOURNAL OF NEUROLOGY, 2011, 258 : 265 - 266
- [3] ProspeCtive study to evaluate efficacy, safety and tOlerability of dietary supplemeNT of Curcumin (BCM95) in subjects with Active relapsing MultIple Sclerosis treated with subcutaNeous Interferon beta 1a 44 mcg TIW (CONTAIN): A randomized, controlled trial MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 56